Home
About
Share This
Set as HomepageBuprenorphine
BUPRENORPHINE (Trade Names: Buprenex®, Suboxone®, Subutex®)
Drug Enforcement Administration Office of Diversion Control Drug & Chemical Evaluation Section BUPRENORPHINE (Trade Names: Buprenex®, Suboxone®, Subutex®) February 2011 DEA/OD/ODE Introduction: Buprenorphine was first marketed in the United States in 1985 as a schedule V narcotic analgesic.
About Methadone and Buprenorphine
www.drugpolicy.org . About Methadone . and Buprenorphine . Revised Second Edition
Technical Assistance Publication (TAP) Series, #30, DHHS ...
BUPRENORPHINE: A GUIDE FOR NURSES Technical Assistance Publication (TAP) Series 30 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment 1 Choke Cherry Road Rockville, MD 20857
Buprenorphine: Potential for Abuse
B ULLETI N INTELLIGENCE U. S. DEPARTMENT OF JUSTICE Background Currently, the drug most commonly used in opiate addiction therapy in the United States is methadone, a Schedule II synthetic opiate.
the facts about
the facts about BUPRENORPHINE for Treatment of Opioid Addiction U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment www.samhsa.gov i
Evaluation of the Buprenorphine Waiver Program: Study Overview
Evaluation of the Buprenorphine Waiver Program: Study Overview Purpose The key questions to be addressed by the Evaluation of the Buprenorphine Waiver are described in the Drug Addiction Treatment Act of 2000 (DATA).
How Buprenorphine (Suboxone, Subutex) Works in the brain
Over time (24-72 hours) buprenorphine dissipates, but still creates a limited opioid effect (enough to prevent withdrawal) and continues to block other opioids from attaching to the opioid receptors.
Buprenorphine transdermal patches (Norspan) for chronic ...
December 2005 10 Buprenorphine transdermal patches (Norspan) for chronic severe pain (bu-pre-NOR-fun) Summary Transdermal buprenorphine could be considered in chronic severe pain when lower doses of strong opioids are indicated.
Buprenorphine Dosing Guidelines
Clinical guidelines: buprenorphine treatment of heroin dependence Clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence Authors Lintzeris N, Clark N, Muhleisen P, Ritter A Ali R, Bell J, Gowing L, Hawkin L, Henry Edwards S, Mattick RP, Monheit B ...
buprenorphine, science, studies, naloxone, subutex, suboxone ...
Science Below is a list of scientific references, concerning addiction and treatments. Some allow access to the entire study some need to be purchased or obtained through a library.
